Alemtuzumab markedly reduces chronic GVHD without affecting overall survival in reduced-intensity conditioning sibling allo-SCT for adults with AML

Bibliographic Information

Published
2008-11-24
Rights Information
  • https://www.springer.com/tdm
  • https://www.springer.com/tdm
DOI
  • 10.1038/bmt.2008.375
Publisher
Springer Science and Business Media LLC

Search this article

Journal

Citations (1)*help

See more

Details 詳細情報について

Report a problem

Back to top